glp-1 vomiting class action in michigan semaglutide digestive blockage gastrointestinal obstruction Subocclusive ileus following off-label high-dose semaglutide use in: Endocrinology, Diabetes & Metabolism Case Reports Volume 2025 Issue 4 (2025) Lawsuit filed against glp-1 gi obstruction class action

The commenters noted that this antiquated cost containment mechanism penalizes migration to lower-cost ASC settings and threatens outpatient access to care, with ASC relative weights decreasing by an average of 7 percent each year since 2010 and the proposed 2026 scalar representing the largest projected cut to ASC weights since payment system alignment in 2008

doi: 10.1172/JCI124049 76 SainiKKChaturvediPSinhaASinghMPKhanMAVermaAet al

P = .004)

Although not everyone will experience these effects, it's still important to be aware before undergoing active treatment

the liver also experiences an increase in ketogenesis [40]